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ABSTRACT
The Mouse Phenome Database (MPD; http://www.
jax.org/phenome) is a repository of phenotypic and
genotypic data on commonly used and genetically
diverse inbred strains of mice. Strain characteristics
data are contributed by members of the scientific
community. Electronic access to centralized strain
data enables biomedical researchers to choose
appropriate strains for many systems-based res-
earch applications, including physiological studies,
drug and toxicology testing and modeling disease
processes. MPD provides a community data reposi-
tory and a platform for data analysis and in silico
hypothesis testing. The laboratory mouse is a
premier genetic model for understanding human
biology and pathology; MPD facilitates research
that uses the mouse to identify and determine the
function of genes participating in normal and
disease pathways.
INTRODUCTION
Refer to Table 1 for a list of Supplements, URLs and
abbreviations.
There are many challenges to using the laboratory mouse for
identifying genes underlying complex human diseases. The
past several years have seen major advancements essential to
achieving this goal: reliable genomic sequence is available
from multiple strains and extraordinary efforts are underway to
annotate these data; genotyping methods are more inexpensive
and scalable; large-scale phenotype characterization projects
are supported through more substantial funding mechanisms;
and signiﬁcant groundwork has been laid for the development
ofresearchresourcesandcommunitydatabasestoaccommodate
large quantities of data generated from these efforts. Now the
focus is turning to an even bigger challenge—linking genotype
and phenotype through computational methods that minimize
the expense and long timeframes associated with traditional
genetic approaches to complex trait analysis.
The Mouse Phenome Project was launched as an inter-
national collaboration to complement the mouse genome
sequencing effort. One of the major goals of the project is
to collect phenotypic data generated under standardized
conditions on a deﬁned set of genetically diverse inbred
strains of mice and to make the data available in a central,
web-accessible database (1). The Mouse Phenome Database
(MPD; http://www.jax.org/phenome), housed at The Jackson
Laboratory, is a data repository and facility for query, data
retrieval and analysis (2). Directories of MPD content are
accessible through the MPD homepage (see also Table 2).
MPD contains diverse data types from many sources which
are organized into a standard framework conducive to efﬁci-
ent processing and data sharing. The data structures are ﬂexi-
ble and accommodate genomic and biological annotations
and are scalable for managing large quantities of data from
different biological levels (molecular, cellular, organ-system
and whole-animal). MPD is linked to other biological data-
bases such as MGD (3), NCBI dbSNP (4) and Ensembl (5).
Additional information about MPD can be found in Supple-
mentary Data 1.
The Mouse Phenome Project takes advantage of the natural
genetic variation and phenotypic diversity of inbred strains
of mice. Inbred strains have distinct, ﬁxed genotypes and
are effectively homozygous at every location. High-quality
phenotypic data from 30 to 40 sufﬁciently genotyped strains
will facilitate efforts to map function to the genome. To stan-
dardize testing across laboratories and over time, the project
promotes and facilitates phenotyping and genotyping projects
following a set of recommendations proposed by members
of the research community (Supplementary Data 2). Strains
are systematically characterized under controlled conditions
by experts in their ﬁelds who typically are funded through
peer-reviewed mechanisms. Per-animal data are collected,
curated and deposited in MPD. (Data submission guidelines
are posted on the MPD website, Supplementary Data 3.)
The Mouse Phenome Project focuses on a large set of
phenotypically diverse inbred mouse strains. These so-called
Priority Strains are carefully chosen by the research commun-
ity and are periodically reviewed and updated depending on
community input and research trends. The Priority Strain
list is maintained and kept current on the MPD website (Sup-
plementary Data 4). As data are collected, phenotype and
genotype data are indexed for each strain and made available
through a strain’s directory page. The directory contains
links to other databases, such as IMSR (6) and MTB (7)
(see URLs and abbreviations in Table 1). Directories for
individual strains can be accessed through strain name hyper-
links (on MPD web pages) and through the full listing of
strains accessed from the MPD homepage (Supplementary
Data 5).
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We use the term ‘project’ to refer to a dataset submitted by
an investigator along with all its associated documentation
(detailed protocols and environmental conditions of test ani-
mals). A project contains a set of measurements that have
been captured under controlled conditions using deﬁned pro-
tocols. A project includes tabular per-animal data that can be
downloaded in ﬂat ﬁle or Excel format. Summary statistics
are computed from per-animal data and are stored as part
of the project. Projects are issued accession numbers (e.g.
MPD: 99) and are identiﬁed by a mnemonic based on the
principal investigator’s name such as ‘Smith1’. The project
directory is accessible from the MPD homepage (Supplemen-
tary Data 6).
A ‘measurement’ refers to a collection of data points gath-
ered: (i) as part of a particular project, (ii) according to a spe-
ciﬁc detailed protocol and (iii) under identical experimental
conditions. Data are collected on multiple strains (survey
format), where there are sufﬁcient numbers of individual
mice for statistical signiﬁcance (10 per strain for each sex are
recommended). A measurement has a short name, description,
units designator and supplemental information (e.g. age
of animals at testing, treatment regimen or phenotyping
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D644 Nucleic Acids Research, 2007, Vol. 35, Database issueplatform). An example of a measurement and its annotations
follows:
Measurements are catalogued by project and category.
‘Measurement categories’ are collections of measurements
that are relevant to one physiological, anatomical or behav-
ioral area. Standardized vocabularies and ontologies [Mam-
malian Phenotype (MP), Gene Ontology (GO) and Uniﬁed
Medical Language System (UMLS)] are used as sources
for annotation terms. Measurement categories are accessed
through the MPD homepage (Supplementary Data 7). Mea-
surements within a category are often supplied by multiple
unafﬁliated projects and may involve a variety of methods,
protocols, animal ages and other differences. This informa-
tion is speciﬁed in measurement annotations and should be
taken into account when using MPD data.
MPD CONTENTS
Table 3 shows a snapshot of MPD content, including pending
datasets currently under various stages of review. Data for a
wide range of parameters are annotated and stored in MPD
along with submitter’s contact information, detailed protocols
and environmental parameters. Currently MPD contains more
than 900 phenotypic measurements (including pending data);
most are relevant to human health and disease, including ath-
erosclerosis, blood disorders, cancer susceptibility, infectious
disease susceptibility, neurological and behavioral disorders,
sensory function defects, gallstone susceptibility, pulmonary
responsiveness, hypertension, osteoporosis and obesity. New
data pertaining to these and other disease areas will be incor-
porated as it becomes available.
MPD also contains extensive genotypic data, including a
large set of SNPs for 10 million genome-wide locations
consolidated from large-scale genotyping consortia. The most
recent collection includes the NIEHS-Perlegen SNPs for
16 inbred strains (this includes C57BL/6J reference data)
and the Broad SNPs for 49 inbred strains. (These two datasets
alone have allele calls for 8+ million and 138+ thousand
genome-wide locations, respectively.) Parallel gene feature
and function annotations are merged from NCBI, dbSNP
and Ensembl, and each SNP location links to MGI’s Mouse
Gbrowse and dbSNP (see URLs and abbreviations in
Table 1).
MPD FEATURES, TOOLS AND DISPLAYS
In addition to providing downloads of phenotype and
genotype data, MPD provides a number of analysis tools to
support exploratory data analysis and discovery. The ability
to choose strains for a speciﬁc experiment by accessing and
analyzing existing phenotype data can bypass the need for
investigators to invest time and resources (re)characterizing
strains. This functionality, in turn, accelerates research and
leverages existing community resources. To assist researchers
in data analysis, summary statistics are computed from sub-
mitted per-animal data and are available in tabular format.
Tools are provided for visualizing measurement data, com-
paring strains and correlating measurements across all
MPD meas accession
number
MPD:9901 (for this example, MPD: 99 is
the project’s accession number)
Short name BP
Description systolic blood pressure (Hg pressure)
Units mm
Project symbol Smith1
Supplemental Age: 9–10 weeks; 1% NaCl in drinking
water; non-invasive tail-cuff method
Category Cardiovascular
Subcategory Blood pressure, sodium intake.
Table 3. MPD Current Contents (Aug 2006)
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customized datasets of phenotype measurements. Table 4 con-
tains a description of selected MPD tools with reference to
thumbnail views shown in Figure 1. Four demos have been
prepared to illustrate these tools and other MPD features
and displays (Supplementary Data 8–11, indexed in Table 4).
In addition to the standard statistical analysis tools, MPD
provides a number of more advanced user tools. Find Mouse
Models, a powerful criteria-ﬁt tool, enables the identiﬁcation
of those strains best matching a set of user-deﬁned criteria
[Figure 1 (I), Table 4]. Using the best mouse model for a par-
ticular research application helps optimize phenotype-driven
approaches to functionally deﬁne the genome. Figure 2 illus-
trates the power of the Find Mouse Models tool (see more
details in MPD Demo 3, Supplementary Data 10). This tool
aids in ﬁnding mouse strains with certain traits or complex
phenotypes, and further, it helps choose control strains
for speciﬁc applications. As the power of this tool is data-
dependent (quantity and quality), data representing other
medically relevant phenotypic domains and data from
additional levels of comprehensive phenotyping are needed
to identify new, possibly improved, mouse models that
more accurately emulate human disease.
An important goal of the Mouse Phenome Project is to
provide online tools to help researchers link genotype and
phenotype. MPD recently updated a data display whereby
phenotypic data may be viewed alongside SNPs from speci-
ﬁed genes or regions. This interactive tool, illustrated in
Figure 1 (M) and MPD Demo 2 (Supplementary Data 9) is
useful for a quick assessment of possible phenotype–
genotype associations and for selecting strains harboring spe-
ciﬁc polymorphisms in candidate genes or regions of interest.
Strains identiﬁed this way are valuable for hypothesis test-
ing, candidate gene validation and follow-on research. More
sophisticated tools for in silico haplotype association map-
ping will be developed when a consensus is determined
regarding the most effective algorithms to accurately asso-
ciate genotype and phenotype.
Additional information about MPD tools and features can
be found in the FAQ (Supplementary Data 12).
Table 4. MPD Tools and Displays
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Research groups are demonstrating powerful in silico meth-
ods of correlating phenotypes and genotypes—the ultimate
aim being to identify genes or regulatory regions contributing
to complex traits [e.g. see (8–15)]. These studies demonstrate
Figure 1. MPD displays and graphics from selected tools. Thumbnail images
illustrate a variety of MPD visualization and analysis tools. The key for A
through M is shown in Table 4. Learn more about these tools and graphic
output options in MPD Demos 1–4 (Supplementary Data 8–11, Table 1).
Figure 2. Find mouse models—criteria fit tool. This tool helps identify
strains best matching user-specified criteria. Users choose measurements of
interest and specify criteria for each. A search is issued across the entire MPD
and the strains giving the best fit are returned in a results table of statistical
information, ranked by an overall best fit score. We provide an example to
illustrate the power of this tool (see Supplementary Data 10 for more details).
The data in our example are real and are available in MPD. The syndrome in
our example is hypothetical. This figure is not an MPD display but is used to
summarize our findings. For example, a new syndrome has been identified
that involves several independent complex traits. The syndrome is most
severe in females exhibiting a higher than average drinking preference for
NaCl, a lower than average prepulse inhibition (PPI), lower than average
activity levels, a smaller than average corpus callosum, and a greater than
average distance between the mandible infradentale and gonion. Less severe
cases of this syndrome are observed where only some of the syndrome traits
are expressed. For this example, we have to identify the best mouse model for
studying this syndrome and its prevention, diagnosis and treatment. First,
we choose MPD measurements that quantify the five traits of interest.
These measurements are gathered from five different projects that tested
overlapping strain sets. We then apply our criteria to each measurement
and issue a search across the entire MPD. The returned results are in tabular
form and rank strains in order of best match. For this particular example, we
find 129S1/SvImJ females are the only strain (by sex) that meet all criteria.
To find other strains that may exhibit milder forms of the syndrome, we
highlight high- and low-end ouliers in our online results table to help quickly
identify strains with unique complex phenotypes across the five traits
[illustrated in Figure 1(I)]. Supplementary Data 10 shows the MPD results
table for this query. The illustration in our figure here simplifies the results:
there are nine distinct genotypes (strain/sex) which exhibit nine distinct
complex phenotypes. 129S1/SvImJ females are an excellent match for
modeling this syndrome. The other eight genotypes may exhibit milder
forms of the syndrome, or none at all. These strains represent diversity in
the population and would, for example, be excellent to include in drug
studies to identify particular genotypes that react adversely to a test drug, or
not at all.
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plexities of entire pathways simply not accessible through
conventional approaches, thus underscoring the utility and
potential of MPD. The importance of the MPD to the research
community is demonstrated by the steady increase in its use.
COLLABORATIONS
The Mouse Phenome Project seeks to establish new collabo-
rations representing a wide variety of phenotypic domains.
The NIH and other funding agencies support experts in their
ﬁelds of study both for primary phenotyping and for more
in-depth, domain-speciﬁc characterization. Toxicogenomics,
pharmacogenomics and comparative genomic hybridization
approaches are producing powerful datasets. Investigators
are using new technologies for detailed characterization of
behavioral phenotypes, embryo morphology and drug efﬁ-
cacy. Several projects are underway to quantitatively deﬁne
complex phenotypes for arthritis, cancer, infectious diseases,
alcohol sensitivity, sleep disorders, epilepsy, aging, osteo-
porosis, metabolic syndrome, anxiety and other behavioral
disorders.
COMMUNITY OUTREACH AND USER
SUPPORT/FEEDBACK
MPD provides user support through online documentation
and via email (phenome@jax.org). PHENOME-LIST is a
moderated electronic bulletin board http://phenome.jax.org/
phenome/list.html. We welcome user input and suggestions.
Researchers interested in contributing data to MPD or in
collaborating on new phenotyping projects should contact us
at phenome@jax.org. Data submission guidelines are accessi-
ble through the MPD homepage, Supplementary Data 3.
HIGH-LEVEL OVERVIEW
The MPD and software system was ﬁrst released in 2001, and
runs on a Solaris computing platform at The Jackson Labor-
atory data center. MPD implementation is an open source
web-based system that includes integrated dynamic HTML
page generation, data graphing and SQL database compo-
nents. Graphical data presentation is used whenever possible.
Investigator protocols and other supporting documentation
are stored as HTML documents. Data accession and updates
are performed centrally by MPD staff. A variety of Unix utili-
ties and custom-written programs are used in this process.
Phenotypic data
Phenotypic data are assigned accession IDs by ‘measurement’
[e.g. per-animal data—from a red blood cell (RBC) count
assay performed by Smith1 under a deﬁned protocol and
controlled conditions—are assigned to a unique measurement
called RBC, which is accessioned as an entity]. Measurements
are tabulated by strain and sex. Strain means, standard
deviation and error, Z-scores, coefﬁcient of variation and
other statistics are computed which are then added to the
database. For most MPD queries, the unit of analysis is a
strain/sex/measurement (female and male mice are always
analyzed separately). Incoming measurement values are
correlated against all other measurement values in the data-
base (each data point is a strain/sex mean) and all correlation
coefﬁcients are stored.
Genotypic data
SNP data are assembled by merging four sources:
(i) allele tables from source laboratories or NCBI dbSNP,
(ii) genomic location and annotation information from dbSNP,
(iii) genomic annotation from the NCBI mouse genome
assembly and
(iv) genomic annotation from Ensembl.
MPD does not retain ﬂanking sequence or attempt to com-
pute locations for SNPs; instead dbSNP is used as the authori-
tative source for genomic location. For this reason, dual
submission to dbSNP is strongly encouraged so that ongoing
genomic location and annotation can be maintained there.
Source laboratories are also encouraged to submit allele
tables directly to MPD for better efﬁciency in merging the
data. Each source dataset is stored in a separate MPD table.
This approach is necessary to efﬁciently handle the wildly
divergent SNP volumes (anywhere from 28 genome-wide
locations to 8.2+ million locations per dataset) and number
of mouse strains assayed (95% of SNPs are for 17 strains
but 400+ strains are present to a sparser degree); users can
retrieve SNPs from all sources or a single source with
equal performance.
Submitted datasets, computed summary statistics and
database tables are freely downloadable as ﬂat ﬁles. Access
the MPD download center (http://www.jax.org/phenome/
download.html).
Items of interest to developers
URL interface for linking to speciﬁc MPD database views
(http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtn=docs/
linktous); Database documentation/data model/schema
(http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtn=data
model/datamodel); and MPD SNP interface—developer
notes and URL interface (http://phenome.jax.org/pub-cgi/
phenome/mpdcgi?rtn=snps/help#developers).
CITING MPD
The following citation format is suggested when referring to
datasets stored in MPD: Investigators. Project Title. MPDnnn
accession number. MPD website, The Jackson Laboratory,
Bar Harbor, Maine, USA (URL: http://www.jax.org/phen
ome, month and year of download). (Update logs are main-
tained for each project, so download dates are important.)
For general citation of the MPD, cite this article.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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